Inspection of Clinical Investigations by the German Health Authorities
Methods and Findings in Experimental and Clinical Pharmacology 1993 May; 15(4): 229-231
Showing items related by title, author, creator and subject.
Mutual Recognition Agreement: Food and Drug Administration's Progress in Assessing Equivalency of European Union Pharmaceutical Inspection Programs Letter From William J. Scanlon, Director, Health Financing and Public Health Issues to Rep. Thomas Bliley, Jr. and Rep. John D. Dingell on the U.S. Congress, House, Committee on Commerce and Rep. Fred Upton and Rep. Ron Klink on the U.S. Congress, House, Committee on Commerce, Subcommittee on Oversight and Investigations Scanlon, William J. (United States. General Accounting Office [GAO]. Health, Education and Human Services Division, 1999-02-26)
Official Position of the American Academy of Clinical Neuropsychology on Ethical Complaints Made Against Clinical Neuropsychologists During Adversarial Proceedings Sweet, Jerry; Greiffenstein, Manfred; Peck, Ted; Schmidt, Michael (2003-11)